loading
Panoramica Notizia Cronologia dei prezzi Financials Forum Previsione

Hemab Therapeutics Holdings Inc Azioni (COAG) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2026-06-30 2026-03-31
Durata del periodo 3 mesi 3 mesi
Operating Expenses
10.45%
26.08
 23.61
Operating Income/Loss
10.45%
-26.08
 -23.61
Income/Loss From Continuing Operations Before Tax
6.08%
-24.05
 -22.68
Income Tax Expense/Benefit
708.33%
0.097
 0.012
Net Income/Loss
6.45%
-24.15
 -22.69
Basic Average Shares
3,083%
30.11
 0.946
Diluted Average Shares
3,083%
30.11
 0.946
Basic Earnings Per Share
96.66%
-0.80
 -23.98
Diluted Earnings Per Share
96.66%
-0.80
 -23.98

Simile a COAG

ABSI ABSI
$8.25
price down icon 7.09%
ANAB ANAB
$46.61
price down icon 4.31%
RARE RARE
$14.54
price down icon 4.15%
AAPG AAPG
$15.37
price up icon 4.63%
KLRA KLRA
$11.25
price down icon 3.93%
KRSA KRSA
$32.38
price down icon 3.77%
Apri su Yahoo | Apri su Google | Aperto in Finviz | Apri in MarketWatch | Aperto a EDGAR | Aperto su Reuters
Capitalizzazione:     |  Volume (24 ore):